You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Meningioma

Showing 26 - 50 of 662
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Automated Segmentation and Volumetry for Meningioma Using Deep

Completed
  • Meningioma
  • Artificial Intelligence
  • Observation
  • (no location specified)
Oct 13, 2021

Craniopharyngioma, Obesity Trial in Oldenburg

Recruiting
  • Craniopharyngioma
  • Obesity
    • Oldenburg, Niedersachsen, Germany
      Klinikum Oldenburg
    Mar 29, 2022

    Neurocognition & Neuroimaging in Primary BT Patients

    Recruiting
    • Primary Brain Tumor
    • +3 more
      • San Diego, California
        Moores Cancer Center
      Oct 7, 2022

      Frequency and Clinical Phenotype of BAP1 Hereditary

      Recruiting
      • Uveal Melanoma
      • +7 more
        • Columbus, Ohio
          The Ohio State University Wexner Medical Center
        Jul 6, 2022

        Meningioma Trial in Austria, Germany, United States (Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI))

        Active, not recruiting
        • Meningioma
        • Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
        • Phoenix, Arizona
        • +16 more
        Dec 27, 2022

        Brain Cancer Trial in United States (Optune (NovoTTF-100A))

        Active, not recruiting
        • Brain Cancer
        • Optune (NovoTTF-100A)
        • Los Angeles, California
        • +8 more
        Jul 1, 2022

        Semi-automated Segmentation Methods of SSTR PET for Dosimetry

        Not yet recruiting
        • Refractory Meningioma
        • To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
        • (no location specified)
        Sep 8, 2022

        COgnitive DEcline After Radiotherapy Using Advanced MRI

        Recruiting
        • Meningioma
        • PRECODE-MRI
        • Maastricht, Limburg, Netherlands
          Maastricht Radiation Oncology
        Apr 11, 2022

        Cognitive Status After Removal of Skull Base Meningioma

        Recruiting
        • Meningioma
        • +6 more
        • Long-term Cognitive testing
        • Columbus, Ohio
          Ohio State University Wexner Medical Center
        Sep 13, 2021

        Androcur® and Meningioma Development:Genotype-environment

        Recruiting
        • Meningioma
        • oral smears
        • Boulogne-Billancourt, France
          Endocrinology Nutrition Department, Ambroise Paré Hospital, APHP
        Sep 27, 2021

        Cognition, Brain Tumor, Magnetic Resonance Imaging Trial in Gent, Leuven, Wilrijk (behavioral, diagnostic test, other)

        Not yet recruiting
        • Cognition
        • +5 more
        • Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test
        • +3 more
        • Gent, Belgium
        • +2 more
        Feb 3, 2023

        Liquid Biopsy in High-grade Gliomas and Meningiomas

        Recruiting
        • High Grade Glioma
        • High Grade Meningioma
          • Milano, MI, Italy
          • +4 more
          Nov 29, 2022

          Residual, Progressive or Recurrent Grade II or III Meningioma Trial (NEO100)

          Not yet recruiting
          • Residual, Progressive or Recurrent Grade II or III Meningioma
          • (no location specified)
          Aug 25, 2021

          Meningiomas Trial in Boston (Nivolumab - 240 mg, Ipilimumab - 1 mg/kg, Nivolumab - 480 mg)

          Recruiting
          • Meningiomas
          • Nivolumab - 240 mg
          • +4 more
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Jan 3, 2022

          Meningioma Trial in Chicago, Boston (AZD2014)

          Active, not recruiting
          • Meningioma
          • Chicago, Illinois
          • +2 more
          Oct 15, 2022

          Meningioma, Malignant Trial in Beijing (Sintilimab)

          Recruiting
          • Meningioma, Malignant
          • Beijing, Beijing, China
            Beijing TianTan Hospital
          Aug 9, 2021

          Glioblastoma Multiforme, Meningioma Trial in Phoenix (Ribociclib)

          Recruiting
          • Glioblastoma Multiforme
          • Meningioma
          • Phoenix, Arizona
            Barrow Brain and Spine
          Oct 7, 2021

          DOTATOC PET/CT for Imaging NET Patients

          Recruiting
          • Neuroendocrine Tumors
          • +15 more
          • 68Ga-DOTATOC PET/CT
          • 18F-FDG PET/CT
          • Vancouver, British Columbia, Canada
            BC Cancer
          Nov 2, 2022

          MiDura-Study (Neuro-Patch in Duraplasty)

          Recruiting
          • Meningioma
          • +9 more
            • Homburg/Saar, Germany
            • +1 more
            May 30, 2022

            Meningioma Atypical Trial in Milano (Radiosurgery)

            Recruiting
            • Meningioma Atypical
            • Radiosurgery
            • Milano, Italy
              UOC Radioterapia
            Oct 5, 2021

            Aneurysm, AVM, Dural Arteriovenous Fistula, Glioma, Meningioma, Metastasis, Bypass Trial (Laser speckle contrast imaging (LSCI))

            Not yet recruiting
            • Aneurysm, AVM, Dural Arteriovenous Fistula, Glioma, Meningioma, Metastasis, Bypass
            • Laser speckle contrast imaging (LSCI)
            • (no location specified)
            Mar 22, 2022

            Intracranial Meningioma Trial in United States (Everolimus, Bevacizumab)

            Terminated
            Has Results
            • Intracranial Meningioma
            • Orlando, Florida
            • +6 more
            Nov 8, 2021

            Aneurysm, AVM, Dural Arteriovenous Fistula Trial in Bern (Laser speckle contrast imaging (LSCI))

            Completed
            • Aneurysm
            • +5 more
            • Laser speckle contrast imaging (LSCI)
            • Bern, Switzerland
              Department of Neurosurgery
            Apr 11, 2022

            High Grade Meningioma Trial in Boston (Pembrolizumab)

            Active, not recruiting
            • High Grade Meningioma
            • Boston, Massachusetts
            • +1 more
            Jul 29, 2021

            Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

            Active, not recruiting
            • Neuroendocrine Tumors
            • +3 more
            • 90Y-DOTA tyr3-Octreotide
            • +2 more
            • Iowa City, Iowa
              University of Iowa Hospitals and Clinics
            Oct 6, 2022